TipRanks
Corbus Pharmaceuticals (DE:3371)
FRANKFURT:3371
Germany Market
3371
Corbus Pharmaceuticals
RESEARCH TOOLSreports

Corbus Pharmaceuticals (3371) Income Statement

0 Followers

Corbus Pharmaceuticals Income Statement

Last quarter (Q2 2026), Corbus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Corbus Pharmaceuticals's net income was $-35.04M. See Corbus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 881.71K
Gross Profit
$ 0.00$ -600.00K$ 0.00$ -1.49M$ -757.53K
Operating Expenses
$ 85.31M$ 48.12M$ 45.08M$ 33.35M$ 55.23M
Depreciation and Amortization
$ 233.00K$ 600.00K$ 641.00K$ 1.49M$ 1.64M
EBITDA
$ -78.30M$ -37.74M$ -40.10M$ -38.73M$ -42.17M
Operating Income
$ -85.31M$ -48.72M$ -45.08M$ -34.84M$ -55.99M
Other Income/Expenses
$ 6.77M$ 8.51M$ 474.00K$ -7.51M$ 10.35M
Pretax Income
$ -78.54M$ -40.21M$ -44.60M$ -42.35M$ -45.64M
Net Income
$ -78.54M$ -40.21M$ -44.60M$ -55.83M$ -45.55M
Per Share Metrics
Basic EPS
$ -5.90$ -3.68$ -10.31$ -10.15$ -11.13
Diluted EPS
$ -5.90$ -3.68$ -10.31$ -10.15$ -11.13
Weighted Average Shares Outstanding
 13.32M 10.91M 4.33M 4.17M 4.10M
Weighted Average Shares Outstanding (Diluted)
 13.32M 10.91M 4.33M 4.17M 4.10M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History